Curatolo PW, Robertson D: The health consequences of caffeine. Ann Intern Med 98: 641-653, 1983
Google Scholar
Barbier A: Caffeine protects against Parkinson's disease? Trends Pharmacol Sci 22: 500, 2001
Google Scholar
Kaiser SM, Quinn RJ: Adenosine receptors as potential therapeutic targets. Drug Discovery Today 4: 542-551, 1999
Google Scholar
Wu G, Morris SM Jr: Arginine metabolism: Nitric oxide and beyond. Biochem J 336: 1-17, 1998
Google Scholar
Herzfeld A, Raper S: The heterogenity of arginase in rat tissues. Biochem J 153: 469-478, 1976
Google Scholar
Wiesinger H: Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog Neurobiol 64: 365-391, 2001
Google Scholar
Farrer I, Costell M, Grisolia S: Lesch-Nyhan syndrome-like behavior in rats from caffeine ingestion. FEBS Lett 141: 275-278, 1982
Google Scholar
Minana D, Portoles M, Jorda A, Grisolia S: Lesch-Nyhan syndrome, Caffeine model: Increase of purine and pyrimidine enzymes in rat brain. J Neurochem 43: 1556-1560, 1984
Google Scholar
Porembska Z, Kedra M: Early diagnosis of myocardial infarction by arginase determination. Clin Chim Acta 60: 555-561, 1975
Google Scholar
Stroev EA, Makarova VG: In: Laboratory Manual in Biochemistry. Mir, Moscov, 1989, pp 251-255
Google Scholar
Bashrach U, Reches B: Enzymic assay for spermine and spermidine. Anal Biochem 17: 38-48, 1966
Google Scholar
Lowry OHR, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with Folin phenol reagent. J Biol Chem 193: 265-275, 1951
Google Scholar
Mimic-Oka J, Cupic Z, Japundzic I: Effect of adrenal function on level of hepatic and extrahepatic arginase. Experientia 27: 1477-1478, 1971
Google Scholar
Fredholm BB: On the mechanism of action of theophylline and caffeine. Acta Med Scand 217: 149-153, 1985
Google Scholar
Nahorski SR, Rogers KJ: Inhibition of 3′,5′-nucleotide phosphodiesterse and the stimulation of cerebral cyclic AMP formation by biogenic amines in vitro and in vivo. Neuropharmacology 15: 609-612, 1976
Google Scholar
Bellet S, Kostis J, Roman L, DeCastro O: Effect of coffee ingestion on adrenocortical secretion in young men and dogs. Metabolism 18: 1007-1012, 1969
Google Scholar
Fredholm BB: Adenosine actions and adenosine receptors after one-week treatment with caffeine. Acta Physiol Scand 115: 283-286, 1982
Google Scholar
Rosenfeld JL, Duta SD, Chedda GB, Tritsch GL: Purine and pyrimidine inhibitors of arginase. Biochem Biophys Acta 410: 164-166, 1975
Google Scholar
Reddy PUM, Ramana Rao JV: Inhibition of arginase in sheep brain homogenates by some L-amino acids. Experientia 37: 814, 1981
Google Scholar
Byus CV, Russell DH: Ornithine decarboxylase activity: Control by cyclic nucleotides. Science 187: 650-652, 1975
Google Scholar
Colombatto S, Fasulo L, Mondardini A, Nmalabaila A, Grillo MA: Effect of caffeine on ornithine metabolism in rat brain, liver and kidney. Ital J Biochem 38: 75-82, 1989
Google Scholar
Krycevskaya AA, Shugaley VS, Tsvetnenko EZ: Brain and liver arginase and polyamines in the mechanism of arginine protective effect under hypoxia. Bilt Exp Biol Med 4: 445-447, 1981
Google Scholar
Lee C: Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation. Clin Chim Acta 295: 141-154, 2000
Google Scholar
Devasagaya TP, Kamat JP, Mohan H, Kesavan PC: Caffeine as an oxidant: Inhibition of lipid peroxidation induced by reactive oxygen species. Biochim Biophys Acta 1282: 63-70, 1996
Google Scholar
Wu G, Meininger CJ: Arginine nutrition and cardiovascular function. J Nutr 130: 2626-2629, 2000
Google Scholar
Nikolic J: Alcoholic intoxication. In: G.A. Qureshi et al. (eds). Neurochemical Markers of Degenerative Nervous Diseases and Drug Addiction. VSP, 1998, pp 193-221
De Mendoca A, Sebastiao AM, Ribeiro JA: Adenosine: Does it have a neuroprotective role after all? Brain Res Rev 33: 258-274, 2001
Google Scholar
Essayan DM: Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation. Biochem Pharmacol 57: 965-973, 1999
Google Scholar